- Home
- RSSS vs GALT Comparison
RSSS vs GALT Comparison
Compare RSSS & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSSS
- GALT
- Stock Information
- Founded
- RSSS 2006
- GALT 2000
- Country
- RSSS United States
- GALT United States
- Employees
- RSSS N/A
- GALT N/A
- Industry
- RSSS Business Services
- GALT Biotechnology: Pharmaceutical Preparations
- Sector
- RSSS Consumer Discretionary
- GALT Health Care
- Exchange
- RSSS Nasdaq
- GALT Nasdaq
- Market Cap
- RSSS 88.2M
- GALT 83.5M
- IPO Year
- RSSS N/A
- GALT N/A
- Fundamental
- Price
- RSSS $2.81
- GALT $1.29
- Analyst Decision
- RSSS
- GALT Hold
- Analyst Count
- RSSS 0
- GALT 1
- Target Price
- RSSS N/A
- GALT N/A
- AVG Volume (30 Days)
- RSSS 41.6K
- GALT 173.9K
- Earning Date
- RSSS 05-08-2025
- GALT 05-15-2025
- Dividend Yield
- RSSS N/A
- GALT N/A
- EPS Growth
- RSSS N/A
- GALT N/A
- EPS
- RSSS N/A
- GALT N/A
- Revenue
- RSSS $48,753,578.00
- GALT N/A
- Revenue This Year
- RSSS $12.42
- GALT N/A
- Revenue Next Year
- RSSS $7.47
- GALT N/A
- P/E Ratio
- RSSS N/A
- GALT N/A
- Revenue Growth
- RSSS 14.85
- GALT N/A
- 52 Week Low
- RSSS $2.32
- GALT $0.73
- 52 Week High
- RSSS $4.24
- GALT $3.17
- Technical
- Relative Strength Index (RSI)
- RSSS 49.36
- GALT 47.05
- Support Level
- RSSS $2.75
- GALT $1.22
- Resistance Level
- RSSS $2.97
- GALT $1.37
- Average True Range (ATR)
- RSSS 0.15
- GALT 0.08
- MACD
- RSSS -0.02
- GALT 0.00
- Stochastic Oscillator
- RSSS 21.05
- GALT 42.11
About RSSS Research Solutions Inc
Research Solutions Inc is a holding company. The company provides a cloud-based SaaS research intelligence platform consisting of proprietary software and Internet-based interfaces. Its platform also allows customers to find and download digital versions of STM articles. Platforms and Transactions are packaged as a single solution that enables life science and other research-intensive organizations to speed up research and development activities. The company platform allows customers to initiate orders, manage transactions, automate authentication, obtain reports, and connect seamlessly to corporate intranets.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.